52 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.
Children’s Place And 2 Other Stocks Bought By Insiders
Although the Dow Jones traded higher this morning on Friday, there were a few notable insider trades.
iTeos Provides Clinical Development Plans And Promotes Yvonne McGrath, Ph.D. To Chief Scientific Officer
iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today
10 Biggest Price Target Changes For Monday
UBS lifted the price target on Pfizer Inc. (NYSE: PFE) from $52 to $60. Pfizer shares rose 1.5% to $53.56 in pre-market trading.
iTeos Announces New Data For Its Anti-TIGIT Antibody, EOS-448, At The American Society Of Hematology Annual Meeting And TIGIT Therapies Digital Summit 2021
Data from preclinical studies in collaboration with Fred Hutchinson Cancer Research Center will be presented at ASH and provide strong rationale for use of EOS-448 as a single agent and in combination with an
ITeos Therapeutics Q3 EPS $1.86 Up From $(0.48) YoY
ITeos Therapeutics (NASDAQ:ITOS) reported quarterly earnings of $1.86 per share. This is a 487.5 percent increase over losses of $(0.48) per share from the same period last year.
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
SVB Leerink Maintains Outperform on ITeos Therapeutics, Lowers Price Target to $55
SVB Leerink maintains ITeos Therapeutics (NASDAQ:ITOS) with a Outperform and lowers the price target from $56 to $55.